Viewing Study NCT07209059


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-01-01 @ 8:28 AM
Study NCT ID: NCT07209059
Status: RECRUITING
Last Update Posted: 2025-10-06
First Post: 2025-07-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma
Sponsor: National Research Center for Hematology, Russia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module